Fresenius SE & Co KGaA (FRE) PT Set at €50.00 by Morgan Stanley

Morgan Stanley set a €50.00 ($58.14) target price on Fresenius SE & Co KGaA (FRA:FRE) in a research report report published on Thursday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Other equities analysts have also recently issued reports about the company. Deutsche Bank set a €65.00 ($75.58) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, February 12th. Berenberg Bank set a €70.95 ($82.50) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Monday, February 18th. Nord/LB set a €58.00 ($67.44) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Wednesday, February 20th. Warburg Research set a €65.00 ($75.58) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Wednesday, February 20th. Finally, Kepler Capital Markets set a €58.00 ($67.44) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Thursday, February 21st. Ten analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock has an average rating of Buy and a consensus target price of €59.55 ($69.24).

FRE opened at €48.81 ($56.76) on Thursday. Fresenius SE & Co KGaA has a 52-week low of €60.16 ($69.95) and a 52-week high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Recommended Story: How is an ETF different from a mutual fund?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.